Abstract: The present invention provides anti-inflammatory compounds useful in the treatment of diseases and conditions in which inflammation is involved in disease progression or the manifestation of symptoms of the disease or condition.

Abstract: Compounds are described that are active on at least one of PPAR?, PPAR?, and PPAR?, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPAR?, PPAR?, and PPAR?.

Abstract: Systems and methods in accordance with various disclosed embodiments can manage a mirrored virtual target to synchronize the members of the virtual target and/or to verify that the members of the virtual target are synchronized. In one embodiment, a mirrored virtual target is synchronized by first provisioning at least one first internal virtual logical unit (IVLU) corresponding to at least one destination target of the mirrored target and a second IVLU corresponding to a source target of the mirrored target. A write command is first issued, via one or more internal virtual logical units, to each of the destination target members of the mirrored target. When each destination target is available to receive data, as evidenced by a returned transfer ready signal, a read command is provided to the source target via the second internal virtual logical unit. In this manner, a data path between the source and destination targets is established prior to reading data from the source target.

Abstract: A system and a method of testing bridge SAS channels includes a control terminal, a hot-plug bridge interface, a first adaptor, an SAS back plate, and a second adaptor. The control terminal selects an SAS interface as a transmission path for sending a test signal. The hot-plug bridge interface receives and converts the test signal sent from the control terminal. The hot-plug bridge interface has a hot-plug function. The first adaptor is connected to the hot-plug bridge interface and the SAS back plate. The second adaptor is connected between the SAS back plate and a terminal unit. The control terminal sends the test signal and detects a signal under test sent back from the terminal unit, and compares whether they are consistent with each other or not. In this way, the control terminal determines whether the SAS interfaces in the SAS back plate run normally or not.

Abstract: A method of forming a barrier layer and cap comprised of CuSiN for an interconnect. We provide an interconnect opening in a dielectric layer over a semiconductor structure. We form a CuSiN barrier layer over the sidewalls and bottom of the interconnect opening by reacting with the first copper layer. We then form an interconnect over the CuSiN layer filling the interconnect opening. We can form a CuSiN cap layer on the top surface of the interconnect.

Abstract: Compounds with 7-azaindole core structure with activity toward the receptor protein tyrosine kinase c-kit, compositions useful for treatment c-kit-mediate diseases or conditions, and methods of use thereof, are provided. Further provided are methods of c-kit ligand identification and design.

Abstract: The present invention provides a method of inducing stress in a semiconductor device substrate by applying an ion implantation to a gate region before a source/drain annealing process. The source/drain region may then be annealed along with the gate which will cause the gate to expand in certain areas due to said ion implantation. As a result, stress caused by said expansion of the gate is transferred to the channel region in the semiconductor substrate.

Abstract: Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.

Abstract: Compounds active on Ret are described, as well as methods of using such compounds. Also described are crystal structures of Ret surrogates that were determined using X-ray crystallography. The use of such Ret surrogate crystals and structural information can, for example, be used for identifying molecular scaffolds and for developing ligands that bind to and modulate Ret and for identifying improved ligands based on known ligands.

Abstract: Compounds with 7-azaindole core structure with activity toward the receptor protein tyrosine kinase c-kit, compositions useful for treatment c-kit-mediate diseases or conditions, and methods of use thereof, are provided. Further provided are methods of c-kit ligand identification and design.

Abstract: An exemplary method for displaying motherboard alarms includes the steps of: reading status information of the motherboard; classifying the status information, each kind of information corresponding to an alarm category, and each alarm category corresponding to an alarm sound; reading a configuration file; determining whether the parameters of the motherboard comply with parameter ranges set in the configuration file; determining an alarm category and setting a corresponding alarm sound, and displaying alarm interfaces if any parameter of the motherboard does not comply with the parameter ranges set in the configuration file.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

Abstract: Systems and methods in accordance with various embodiments can detect and alleviate potential or actual deadlock of a storage switch or storage area network when attempting to write data to a mirrored virtual target. In accordance with one embodiment, a timer is started when a storage switch routes a write command to the physical targets corresponding to a virtual target of the write command. If each physical target does not return a transfer ready resource within a predetermined timeout period, the switch determines that a potential or actual deadlock has occurred. An abort command is sent to each of the physical devices. The abort command can clear the command from the targets and also free any allocated transfer ready resources. After receiving an acceptance response from each physical target, the state of the write command at the switch can be cleared. The write command can then be re-issued to the physical devices.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

Abstract: A scene-based non-uniformity correction method employing local constant statistics for eliminating fixed pattern noise in a video comprising a plurality of images is disclosed, comprising the steps of providing an initial gain image, an initial offset image, a predetermined pyramid level, and a filter of a predetermined level; setting one of the plurality of input images to the current image; calculating a temporary true scene image for the current image based on the initial gain image and the initial offset image; accumulating a temporal mean image and a temporal standard deviation image based on the calculated temporary true scene image; setting another of the plurality of images to the current image and repeating the setting, calculating, and accumulating steps until substantially all of the images of the plurality of images have been processed, otherwise further perform the steps of calculating a Gaussian mean image based on the accumulated temporal mean and calculating a Gaussian gain image based on the

Abstract: Compounds are described that are active on at least one of PPAR?, PPAR?, and PPAR?, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPAR?, PPAR?, and PPAR?.

Abstract: Compounds are described that are active on at least one of PPAR?, PPAR?, and PPAR?, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPAR?, PPAR?, and PPAR?.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. The invention further relates to pharmaceutical compositions and methods of preventing or treating disease with 1H-Pyrrolo[2.3-d]pyrimidine derivatives. More specifically, the invention relates to a 1H-Pyrrolo[2.

Abstract: Compounds are described that are active on at least one of PPAR?, PPAR?, and PPAR?, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPAR?, PPAR?, and PPAR?.

Abstract: Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.